Safety and Toxicity of Saw Palmetto in the CAMUS Trial-Reference-Cited by-同舟云学术

Safety and Toxicity of Saw Palmetto in the CAMUS Trial

Published:2013-04 Issue:4 Volume:189 Page:1415-1420
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Avins Andrew L.¹,Lee Jeannette Y.²,Meyers Catherine M.³,Barry Michael J.⁴,

Affiliation:

1. Northern California Kaiser-Permanente Division of Research, Oakland and Departments of Medicine and Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, California

2. Department of Biostatistics, University of Arkansas for Medical Sciences, Little Rock, Arkansas

3. National Center for Complementary and Alternative Medicine, National Institutes of Health, Bethesda, Maryland

4. General Medicine Division, Massachusetts General Hospital, Boston, Massachusetts

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference27 articles.

1. Complementary and alternative medicine use among adults and children: United States, 2007;Barnes;Natl Health Stat Report,2008

2. Serenoa repens for benign prostatic hyperplasia;Tacklind;Cochrane Database Syst Rev,2009

3. Saw palmetto and lower urinary tract symptoms: what is the latest evidence?;Avins;Curr Urol Reports,2006

4. Saw palmetto extracts for treatment of benign prostatic hyperplasia;Wilt;JAMA,1998

5. Serenoa repens for benign prostatic hyperplasia;Wilt;Cochrane Database Syst Rev,2000

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of Coagulopathy and Pancreatitis Due to Saw Palmetto Used for Urinary Symptoms;Anatolian Journal of Emergency Medicine;2024-06-29

2. Emerging drugs for the treatment of benign prostatic hyperplasia: a 2023 update;Expert Opinion on Emerging Drugs;2024-06-14

3. Saw Palmetto Treatment for Prostatitis: A Systematic Review of the Literature;JU Open Plus;2024-02

4. Nutritional supplements;Procedures in Cosmetic Dermatology: Hair Restoration;2024

5. Serenoa repens for the treatment of lower urinary tract symptoms due to benign prostatic enlargement;Cochrane Database of Systematic Reviews;2023-06-22